Suchergebnisse - "Clinical Trial, Phase II"

PubPharm (41.137)

1

Impact of PIK3CA and cell cycle pathway genetic alterations on durvalumab efficacy in patients with head and neck squamous cell carcinoma : Post hoc analysis of TRIUMPH study

enthalten in: Oral oncology | 2024

von Kim, D. | Lim, S. | Kim, H. | +12

2

Phase II Study of Osimertinib in Patients With Epidermal Growth Factor Receptor Mutations : Results From the NCI-MATCH ECOG-ACRIN (EAY131) Trial Subprotocol E

enthalten in: JCO precision oncology | 2024

von Chen, M. | Song, Z. | Yu, H. | +19

3

Atezolizumab plus modified docetaxel, cisplatin, and fluorouracil as first-line treatment for advanced anal cancer (SCARCE C17-02 PRODIGE 60) : a randomised, non-comparative, phase 2 study

enthalten in: The Lancet. Oncology | 2024

von Kim, S. | Ghiringhelli, F. | de la Fouchardière, C. | +25

4

LOAd703, an oncolytic virus-based immunostimulatory gene therapy, combined with chemotherapy for unresectable or metastatic pancreatic cancer (LOKON001) : results from arm 1 of a non-randomised, single-centre, phase 1/2 study

enthalten in: The Lancet. Oncology | 2024

von Musher, B. | Rowinsky, E. | Smaglo, B. | +17

5

FRONTIER1 : a partially randomized phase 2 study assessing the safety, pharmacokinetics, and pharmacodynamics of Mim8, a factor VIIIa mimetic

enthalten in: Journal of thrombosis and haemostasis : JTH | 2024

von Lentz, S. | Chowdary, P. | Gil, L. | +5

6

MRI-guided stereotactic ablative body radiotherapy versus CT-guided percutaneous irreversible electroporation for locally advanced pancreatic cancer (CROSSFIRE) : a single-centre, open-label, randomised phase 2 trial

enthalten in: The lancet. Gastroenterology & hepatology | 2024

von Timmer, F. | Geboers, B. | Ruarus, A. | +17

7

Switching from FOLFIRI plus cetuximab to FOLFIRI plus bevacizumab based on early tumor shrinkage in RAS wild-type metastatic colorectal cancer : A phase II trial (HYBRID)

enthalten in: Cancer medicine | 2024

von Arai, H. | Tsuda, T. | Sunakawa, Y. | +13

8

Nintedanib plus Chemotherapy for Small Cell Lung Cancer with Comorbid Idiopathic Pulmonary Fibrosis

enthalten in: Annals of the American Thoracic Society | 2024

von Ikeda, S. | Ogura, T. | Kato, T. | +14

9

Trastuzumab deruxtecan in patients with metastatic non-small-cell lung cancer (DESTINY-Lung01) : primary results of the HER2-overexpressing cohorts from a single-arm, phase 2 trial

enthalten in: The Lancet. Oncology | 2024

von Smit, E. | Felip, E. | Uprety, D. | +17

10

A randomized trial to assess the acceleration of viral clearance by the combination Favipiravir/Ivermectin/Niclosamide in mild-to-moderate COVID-19 adult patients (FINCOV)

enthalten in: Journal of infection and public health | 2024

von Siripongboonsitti, T. | Tawinprai, K. | Avirutnan, P. | +2

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[4114]